Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Mar 06, 2023 5:46pm
170 Views
Post# 35322423

RE:RE:RE:RE:RE:RE:RE:Quote by Warren Buffet

RE:RE:RE:RE:RE:RE:RE:Quote by Warren BuffetAs expected. Here's what was offered on October 3rd '22, with closing expected Oct 14th:

Under the terms of the Financing, up to 10,000,000 Units are available to be sold to accredited investors at a price of $0.25 per Unit for aggregate gross proceeds of up to $CAN 2,500,000.

Here's what was closed on Nov 16th:

On closing, the Corporation issued an aggregate of 1,000,000 Units at a price of $0.25 per Unit for aggregate gross proceeds of approximately $250,000. 
.... 

An aggregate of 511,000  Units, representing gross proceeds of $127,750, were issued to certain insiders of the Corporation. 

Since the total buy is less than 25% of total MC, the company did not need special approval from shareholders. So another $125K was bought by others. Or about 1/20th of available starting estimate.  Does that qualify as massive interest in your world?  Don't hesitate to respond.  If you do respond, tell me why accredited investors will be interested if we do a raise again.

Remember, it's real money we're investing and we all own shares. Take it away.
 
<< Previous
Bullboard Posts
Next >>